June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Generali's MetLife gambit hits price snag - sources

Published 03/12/2019, 13:22
Updated 03/12/2019, 13:25
Generali's MetLife gambit hits price snag - sources
PRU
-
GASI
-
AXAF
-
ABDN
-
MET
-

By Pamela Barbaglia and Carolyn Cohn

LONDON (Reuters) - Italian insurer Assicurazioni Generali (MI:GASI) has held talks with U.S. rival MetLife Inc (N:MET) to buy the bulk of its European assets but discussions have stalled due to differences over price, four sources told Reuters.

Generali, which ranks as Europe's third biggest insurer, first approached MetLife earlier this year offering to take on most of its underperforming European business whose adjusted earnings slipped 4% in the third quarter, the sources said.

But talks dragged on for more than six months and were hampered by management changes at MetLife, where Michel Khalaf became the New York-based insurer's new boss in May, they said.

Representatives at Generali and MetLife declined to comment.

Two of the sources said Generali remained interested in hoovering up a significant chunk of MetLife's European portfolio, including operations in Britain, France, Italy and eastern Europe, but no agreement could be reached.

They said the price and structure of the deal were the main stumbling blocks and ruled out any progress by the end of the year.

MetLife's Khalaf emailed staff in late November saying there were no live discussions with the Italian insurer after media reports first emerged.

"Negotiations have been on and off for months. There are still many aspects of the deal that need fine-tuning including the valuation," a source familiar with the discussions said, ruling out any near-term agreement.

Generali has about 3 billion euros ($3.31 billion) for acquisitions, under its latest strategy plan, and its French boss Philippe Donnet is looking at several dossiers, according to a source close to the situation.

Any deal must come at a fair price and unlock significant synergies, this source said.

Generali wants to boost its presence in certain European countries to drive earnings after pulling back from non-core markets including Belgium and the Netherlands last year.

SLOW-MOVING

MetLife operates in 26 countries across Europe, the Middle East and Africa (EMEA), offering life, accident, health and credit insurance, as well as pension products.

The U.S. insurer runs the bulk of its European assets out of Ireland where its main subsidiary - MetLife Europe d.a.c. - has operations in 11 countries including Britain, Italy, Spain and France.

MetLife controls three other subsidiaries active in Europe and known as MetLife Europe Insurance d.a.c., MetLife Greece S.A. and MetLife TUnZiR in Poland.

The sources said Generali had carried out due diligence on all the divisions, aiming to buy most of the operations including activities in Greece and Poland. But MetLife was reluctant to sell its entire European portfolio unless the price was compelling.

Another source familiar with Generali's strategy said the Trieste-based company was still looking at MetLife's businesses, but said Generali would only resume efforts to negotiate a deal after its annual results due on March 14, 2020.

The source said that although things were moving slowly the talks could gain traction next year.

Investors are expected to quiz MetLife on its plans for Europe at a New York investor conference on Dec. 12.

MetLife's EMEA business is the smallest of the U.S. group's five businesses, with adjusted earnings of $277 million in 2018, compared with $2.8 billion for its U.S. operations and $5.6 billion for the group.

Insurers in Europe such as Old Mutual, Prudential (L:PRU) and Standard Life (L:SLA) have been streamlining their businesses via disposals and mergers to grapple with tougher regulatory scrutiny, low interest rates and fierce competition.

French insurer AXA (PA:AXAF) is also considering selling its central European business as part of a restructuring to quit markets where it lacks scale, Reuters reported in October.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.